Shingles in HIV: Outcome and discovery
International Journal of STD & AIDS · 2025
DOI: 10.1177/09564624251324975 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2025. Verfasst von Mouna Guechchati und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Hassan II University Hospital, Fez, Morocco. Hauptthemen laut MEDLINE: HIV Infections, Herpes Zoster. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Background
Herpes zoster (HZ) is a frequent manifestation in people living with HIV (PLHIV), with a significantly higher incidence compared to the general population. It often presents as an early indicator of immunosuppression, making timely diagnosis and treatment crucial.
Methods
This retrospective study, conducted from January 2015 to September 2024, analyzed 45 PLHIV diagnosed with HZ. Patients were recruited from the Infectious Diseases Department (for HIV-related HZ cases) and the Dermatology Department (for complicated HZ cases requiring hospitalization). Clinical and demographic data were collected, including ART status, HZ presentation, and treatment outcomes.
Results
The mean patient age was 36.35 years, with a male predominance (M/F ratio: 8). Among the cohort, 12 patients had undiagnosed HIV, and HZ was the presenting symptom that led to HIV diagnosis. The thoracic metameric variant was the most common, with erythematous-vesicular, necrotic-hemorrhagic, and bullous forms observed. 21 patients were on antiretroviral therapy (ART), six of whom developed HZ shortly after ART initiation. Treatment involved oral or intravenous acyclovir, with hospitalization required for complicated or multi-metameric forms and high-risk patients. Outpatient management with close monitoring was provided for stable cases.
Conclusions
HZ remains a significant opportunistic infection in PLHIV, often serving as a sentinel sign of undiagnosed HIV. Early HIV screening in patients presenting with HZ and timely initiation of antiviral therapy are essential for improved outcomes. Enhanced awareness and integrated HIV-HZ management strategies are crucial in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology Department, Hassan II University Hospital, Fez, Morocco.
- Infectiology Department, Hassan II University Hospital, Fez, Morocco.
ORCID-Profile: Mouna Guechchati
Zitieren
APA
Guechchati, M., Soughi, M., Rabhi, S., Idrissi Janati, H., Douhi, Z., Elloudi, S., Baybay, H., & Mernissi, F. Z. (2025). Shingles in HIV: Outcome and discovery. International Journal of STD & AIDS. https://doi.org/10.1177/09564624251324975
Vancouver
Guechchati M, Soughi M, Rabhi S, Idrissi Janati H, Douhi Z, Elloudi S, et al. Shingles in HIV: Outcome and discovery. International Journal of STD & AIDS. 2025. doi:10.1177/09564624251324975
BibTeX
@article{Guechchati2025,
author = {Guechchati, Mouna and Soughi, Meryem and Rabhi, Samira and Idrissi Janati, Hamza and Douhi, Zakia and Elloudi, Sara and Baybay, Hanane and Mernissi, Fatima Zahra},
title = {Shingles in HIV: Outcome and discovery},
journal = {International Journal of STD & AIDS},
year = {2025},
doi = {10.1177/09564624251324975}
}
EUVIMED